Q97859236

Summary

Q97859236 is an individual motion^[1].

Key Facts

• Q97859236 authored Jan Lindholm^[2].
• Q97859236's instance of is recorded as individual motion^[3].
• Q97859236's part of the series is recorded as motions of the 2005-2006 legislative session of the Riksdag^[4].
• Q97859236's language of work or name is recorded as Swedish^[5].
• Q97859236 was released on +2005-09-29T00:00:00Z^[6].
• Q97859236's main subject is medication^[7].
• Q97859236's work available at URL is recorded as http://data.riksdagen.se/dokument/GT02So381^[8].
• Q97859236's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GT02So381^[9].
• Q97859236's applies to jurisdiction is recorded as Sweden^[10].
• Q97859236's legal citation of this text is recorded as Mot. 2005/06:So381^[11].
• Q97859236's title is recorded as Rapportering av läkemedelsbiverkningar^[12].
• Q97859236's maintained by WikiProject is recorded as Project Riksdagen's documents^[13].
• Q97859236's copyright status is recorded as public domain^[14].
• Q97859236's legislative committee is recorded as Committee on Health and Welfare^[15].

Body

Definition and Type

Q97859236's instance of is recorded as individual motion^[3].